Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Aquestive Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 64 | 60 | −4 |
| Shares | 16.6M | 15.6M | −1.01M (−6.0%) |
| Value | $86.4M | $62.0M | −$24.4M (−28.2%) |
New holders (21)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 437,854 | $1.74M | 0.00% |
| Renaissance Technologies LLC | 245,448 | $974.0K | 0.00% |
| Latash Investments, LLC | 243,134 | $965.0K | 0.61% |
| Caas Capital Management LP | 217,091 | $862.0K | 0.05% |
| Alberta Investment Management Corp | 150,000 | $596.0K | 0.00% |
| Ergoteles LLC | 90,900 | $361.0K | 0.01% |
| PDT Partners, LLC | 81,765 | $325.0K | 0.02% |
| Tibra Equities Europe Ltd | 78,100 | $310.0K | 0.10% |
| HRT Financial LP | 49,907 | $198.0K | 0.00% |
| Jump Financial, LLC | 30,630 | $122.0K | 0.01% |
| Cresset Asset Management, LLC | 25,000 | $99.0K | 0.00% |
| Squarepoint Ops LLC | 19,824 | $79.0K | 0.00% |
| Virtu Financial LLC | 18,521 | $74.0K | 0.01% |
| Susquehanna Fundamental Investments, LLC | 15,644 | $62.0K | 0.00% |
| ExodusPoint Capital Management, LP | 13,399 | $53.0K | 0.00% |
| LMR Partners LLP | 12,090 | $48.0K | 0.00% |
| First Manhattan Co | 2,600 | $10.0K | 0.00% |
| Advisor Group Holdings, Inc. | 2,000 | $8.00K | 0.00% |
| Advisory Services Network, LLC | 800 | $3.00K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
| Strategic Blueprint, LLC | 9 | $0 | 0.00% |
Sold out (25)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.